News | January 26, 2009

Medtronic Starts VITALITY Post-Market Study of the Talent Abdominal Stent Graft

January 27, 2009 - Medtronic Inc. today reported the first enrollment in VITALITY, the company’s post-market clinical study of its Talent Abdominal Stent Graft for the endovascular repair of abdominal aortic aneurysms.

“VITALITY will gather clinically relevant data on the safety and efficacy of the Talent Abdominal Stent Graft in a real-world U.S. patient population,” said vascular surgeon George Pliagas, M.D., who led the team at St. Mary’s Medical Center in Knoxville, TN, which performed the first study implant on Dec. 29.

“Internationally, the device and delivery system have an excellent track record,” Dr. Pliagas said. “The Talent Stent Graft System is known to be accurate, durable and easy to use, and I expect that U.S. physicians will have similar sentiments as it gains broader market acceptance.”

The Talent Abdominal Stent Graft expands the applicability of endovascular aneurysm repair (EVAR), enabling more patients to benefit from a minimally invasive alternative to open surgical repair. It is the only stent graft approved by the FDA for use in the treatment of abdominal aortic aneurysms with proximal necks (“landing zones”) as short as 10 mm. The Talent Abdominal Stent Graft has been used internationally for more than 12 years and, during that time, implanted in more than 45,000 patients.
Addressing a condition of FDA approval, VITALITY will involve a total of 260 subjects and up to 30 U.S. sites. The study’s primary endpoint is freedom from aneurysm-related mortality (ARM) at five years, with ARM defined as death from aneurysm rupture or from any procedure intended to prevent it. The study design incorporates the test group of 166 patients from the earlier study that supported the device’s FDA approval in 2008, as well as an additional 94 new subjects to be prospectively enrolled. All subjects will be followed for five years. Luis Sanchez, M.D., of Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, MO., has been chosen as VITALITY’s principal investigator.

An aortic aneurysm is a dangerous bulge or weakening in the body’s main artery that can rupture with fatal consequences if left untreated. According to the Society for Vascular Surgery, abdominal aortic aneurysms – the most common type – are responsible for approximately 15,000 U.S. deaths annually; it is estimated that more than one million people are living with undiagnosed aortic aneurysms, and that 95 percent of these could be successfully treated if detected before rupture.

EVAR involves the navigation of a stent graft - a fabric tube reinforced with a metal mesh - via the body’s arteries to the aorta. The stent graft is then deployed, allowing blood flow through the aorta while reducing pressure on the aneurysm and the risk of rupture.

For more information: www.medtronic.com

Related Content

Gore Announces First-in-Human Use of Gore TAG Conformable Thoracic Stent Graft
News | Stent Grafts| July 17, 2017
W. L. Gore & Associates Inc. announced the first patient implant of the Gore TAG Conformable Thoracic Stent Graft...
New Paper Highlights Success of Advanced Treatments in Complex Aortic Aneurysm Repair
News | Endovascular Aortic Repair| May 23, 2017
Significant success has been achieved in treating complex proximal aneurysms using a combination of fenestrated and...
News | Stent Grafts| April 06, 2017
Endologix Inc. announced that the first patients were treated in the Expanding Patient Applicability with Polymer...
Gore, Viabahn VBX Balloon Expandable Endoprosthesis, stent graft, iliac artery, FDA approval
Technology | Stent Grafts| January 31, 2017
W. L. Gore & Associates (Gore) announced that the Gore Viabahn VBX Balloon Expandable Endoprosthesis (VBX Stent...
Lombard Medical, Aorfix endovascular stent graft, Japanese regulatory approval, IntellFlex LP Delivery System
News | Stent Grafts| January 11, 2017
January 11, 2017 — Lombard Medical Inc.
stent grafts, fluid flow model, clotting risk, Journal of Vascular Surgery

An anterior view is shown of the geometries of each of the graft configurations: (A) fenestrated, (B) antegrade branched, (C) retrograde branched, and (D) manifold stent graft. Image courtesy of Taylor Suess, et al.

News | Stent Grafts| January 05, 2017
January 5, 2017 — Whether patients with mechanical heart valves and stents must take blood thinners depends on how ef
News | Stent Grafts| December 13, 2016
Lombard Medical Inc. announced that its Altura endovascular stent graft system was featured in a scientific...
aorfix, lombard medical, EVAR,
News | September 06, 2016 | Dave Fornell
September 5, 2016 — Lombard Medical Inc., a company focused on endovascular aneurysm repair (EVAR) of abdominal aorti
Gore, DrySeal Flex Introducer Sheath, endovascular repair, EVAR
Technology | Vascular Access| August 30, 2016
W. L. Gore & Associates Inc. (Gore) announced the commercial availability of the Gore DrySeal Flex Introducer...
News | Stent Grafts| August 19, 2016
Endologix Inc. announced the first two patients with abdominal aortic aneurysms (AAA) have been treated with the...
Overlay Init